MedPath

重庆赛诺生物药业股份有限公司

Ownership
-
Established
1995-12-14
Employees
-
Market Cap
-
Website
www.cqsino.cn

Clinical Trials

0

Active:0
Completed:0

Trial Phases

0 Phases

Drug Approvals

15

NMPA:15

Drug Approvals

Polyethylene Glycol Electrolytes Powder（III）

Product Name
复方聚乙二醇电解质散(Ⅲ)
Approval Number
国药准字H20253888
Approval Date
Apr 15, 2025
NMPA

Macrogol 4000 Powder

Product Name
聚乙二醇4000散
Approval Number
国药准字H20244354
Approval Date
Jun 28, 2024
NMPA

辛芳鼻炎胶囊

Approval Number
国药准字Z19993336
Approval Date
Aug 5, 2020
NMPA

生桂口服液

Approval Number
国药准字B20020375
Approval Date
Aug 5, 2020
NMPA

杞菊地黄胶囊

Approval Number
国药准字Z50020011
Approval Date
Aug 5, 2020
NMPA

妇科十味片

Approval Number
国药准字Z19993335
Approval Date
Aug 5, 2020
NMPA

蛇胆陈皮液

Approval Number
国药准字Z19983140
Approval Date
Aug 5, 2020
NMPA

复方感冒灵片

Approval Number
国药准字Z19994003
Approval Date
Aug 5, 2020
NMPA

决明降脂片

Approval Number
国药准字Z50020010
Approval Date
Aug 5, 2020
NMPA

桂枝合剂

Approval Number
国药准字Z50020009
Approval Date
Aug 5, 2020
NMPA
  • Prev
  • 1
  • 2
  • Next

Clinical Trials

No trials found

News

No news found

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.